503-222-1261 info@crgpdx.com

Hyperlipidemia

This is a multicenter, 12-week treatment period study to evaluate the safety, tolerability and efficacy of 3 doses of study drug compared to placebo in patients 18 years of age and older with fasting triglyceride levels between 500 mg/dl and…

Read More

Osteoarthritis

This is a phase 3, multicenter study evaluating the safety, tolerability and efficacy of a single dose of study drug injected in the target knee joint of moderately to severely symptomatic osteoarthritis patients. The study is 26 weeks in duration…

Read More